Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

PT Kalbe Farma Tbk. (LCLA.F)

Compare
0.0555
+0.0005
+(0.91%)
At close: April 11 at 3:29:02 PM GMT+2
Loading Chart for LCLA.F
  • Previous Close 0.0550
  • Open 0.0545
  • Bid 0.0555 x 10000000
  • Ask 0.0735 x 10000000
  • Day's Range 0.0545 - 0.0555
  • 52 Week Range 0.0050 - 0.0950
  • Volume 50,000
  • Avg. Volume 781
  • Market Cap (intraday) 2.859B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date Apr 29, 2025 - May 5, 2025
  • Forward Dividend & Yield 0.00 (3.11%)
  • Ex-Dividend Date May 29, 2024
  • 1y Target Est --

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

www.kalbe.co.id

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LCLA.F

View More

Performance Overview: LCLA.F

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

LCLA.F
14.62%
IDX COMPOSITE (^JKSE)
11.55%

1-Year Return

LCLA.F
100.20%
IDX COMPOSITE (^JKSE)
14.06%

3-Year Return

LCLA.F
100.00%
IDX COMPOSITE (^JKSE)
13.07%

5-Year Return

LCLA.F
100.00%
IDX COMPOSITE (^JKSE)
34.70%

Compare To: LCLA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LCLA.F

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    2.86B

  • Enterprise Value

    2.63B

  • Trailing P/E

    15.00

  • Forward P/E

    14.06

  • PEG Ratio (5yr expected)

    1.29

  • Price/Sales (ttm)

    1.49

  • Price/Book (mrq)

    2.12

  • Enterprise Value/Revenue

    1.53

  • Enterprise Value/EBITDA

    10.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.93%

  • Return on Assets (ttm)

    9.03%

  • Return on Equity (ttm)

    13.61%

  • Revenue (ttm)

    32.63T

  • Net Income Avi to Common (ttm)

    3.24T

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.72T

  • Total Debt/Equity (mrq)

    2.28%

  • Levered Free Cash Flow (ttm)

    2.24T

Research Analysis: LCLA.F

View More

Company Insights: LCLA.F

Research Reports: LCLA.F

View More

People Also Watch